Gross Profit: Revenues from operations less the associated costs.
Tvardi Therapeutics, Inc. (TVRD) Gross Profit data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$4.17M |
|
-- |
|
|
Gross Profit |
-- |
$8.87M |
|
$-8.87M |
|
$13.04M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
$-8.87M |
|
$-8.87M |
|
8.25M |
|
8.46M |
|
$0.51 |
|
$-1.00 |
|
| Balance Sheet Financials | |
$43.13M |
|
$0.07M |
|
$0.62M |
|
$43.75M |
|
$10.68M |
|
-- |
|
$0.14M |
|
$10.82M |
|
$32.93M |
|
$32.57M |
|
$32.93M |
|
9.37M |
|
| Cash Flow Statement Financials | |
$-13.56M |
|
$-20.43M |
|
$23.02M |
|
$31.61M |
|
$20.65M |
|
$-10.97M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.66% |
|
12.79% |
|
9.52% |
|
12.66% |
|
$3.51 |
|
$-1.60 |
|
$-1.60 |
|